Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Explore how Insilico collaborates with Servier to advance AI-driven drug discovery in oncology for unmet medical needs.

Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...

InSilico Medicine Cayman TopCo, an artificial intelligence drug discovery startup, said on Monday that it has secured a ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

Smart multi-target drugs are reshaping modern therapeutics by addressing the complex, interconnected pathways that drive diseases like Alzheimer’s, cancer, and major depressive disorder. Advances in ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development continue to face a multitude of obstacles, such as complex methodologies, high ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Fannin Partners and Allterum Therapeutics, Inc. are pleased to announce that Brian Wipke, Ph.D., an accomplished immunologist and drug discovery and development leader with more than 20 years of ...